HTFL Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

32.460

Open

31.910

VWAP

31.43

Vol

1.73M

Mkt Cap

2.67B

Low

30.850

Amount

54.42M

EV/EBITDA(TTM)

--

Total Shares

86.24M

EV

2.58B

EV/OCF(TTM)

--

P/S(TTM)

12.46

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Show More

Events Timeline

(ET)

2026-05-14

16:20:00

Heartflow Reports Q1 Revenue of $52.59M, Beating Expectations

2026-05-14

16:20:00

FY26 Gross Margin View Narrowed to 81%

2026-04-13 (ET)

2026-04-13

09:10:00

Heartflow Sues Cleerly for Patent Infringement in Texas

2026-03-18 (ET)

2026-03-18

18:30:00

US Stocks Drop on Iranian Energy Attacks and Inflation Data

2026-03-18

16:20:00

Heartflow Q4 Revenue $49.13M Beats Expectations

News

seekingalpha

05-15seekingalpha

HeartFlow Reports Strong Q1 2026 Earnings with Raised Revenue Outlook

Fool

SpaceX Could Become Largest IPO in History

Globenewswire

05-11Globenewswire

MindBio Launches AI Voice Detection Technology for Intoxication

Newsfilter

05-11Newsfilter

MindBio Launches AI Voice Detection Technology for Intoxication

Fool

Stanford University Fully Exits HeartFlow Investment

Yahoo Finance

05-08Yahoo Finance

Baron Discovery Fund Q1 2026 Investor Letter Released

5 Analyst Rating

Wall Street analysts forecast HTFL stock price to rise

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Canaccord

Buy

downgrade

$43 -> $37

AI Analysis

2026-05-15

Reason

Canaccord

Price Target

$43 -> $37

AI Analysis

2026-05-15

downgrade

Buy

Reason

Canaccord lowered the firm's price target on Heartflow to $37 from $43 and keeps a Buy rating on the shares. The firm said Heartflow reported a solid beat-and-raise, with guidance reflecting the strong momentum the company is seeing. Canaccord said despite raising our revenue estimates, they are lowering their target due to the decline in the comp group multiple as the sector remains under pressure.

Wells Fargo

Larry Biegelsen

Overweight

maintain

$35 -> $37

2026-05-15

Reason

Wells Fargo

Larry Biegelsen

Price Target

$35 -> $37

2026-05-15

maintain

Overweight

Reason

Wells Fargo analyst Larry Biegelsen raised the firm's price target on Heartflow to $37 from $35 and keeps an Overweight rating on the shares. The firm notes the company reported a $3M Q1 sales beat and raised full-year sales guidance by $10M as Plaque is tracking ahead of prior expectations and FFRCT is performing well. Management signaled guidance is de-risked and there remains upside.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HTFL

Unlock Now

Valuation Metrics

The current forward P/E ratio for Heartflow Inc (HTFL.O) is 0.00, compared to its 5-year average forward P/E of -53.73. For a more detailed relative valuation and DCF analysis to assess Heartflow Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-53.73

Current PE

0.00

Overvalued PE

-44.01

Undervalued PE

-63.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-42.83

Current EV/EBITDA

-25.00

Overvalued EV/EBITDA

-20.56

Undervalued EV/EBITDA

-65.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

11.21

Current PS

9.66

Overvalued PS

14.33

Undervalued PS

8.09

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stock for buy and sell today

Intellectia · 241 candidates

Market Cap: >= 500.00MPrice: $3.00 - $200.00Price Change Pct: $-50.00 - $-1.00Monthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

Bright Horizons Family Solutions Inc

4.63B

Upstream Bio Inc

691.69M

Pinterest Inc

12.52B

Fortune Brands Innovations Inc

7.48B

Draftkings Inc

22.41B

Rich Sparkle Holdings Ltd

778.75M

US MARKETS , ALL SECTORS

Intellectia · 158 candidates

Dividend Yield Ttm: >= 0Debt Equity: <= 1Pe Ttm: <= 10

Ticker

Name

Market Cap$

QXO Inc

15.83B

Bitmine Immersion Technologies Inc

13.35B

CG Oncology Inc

4.61B

SoundHound AI Inc

4.46B

Arcellx Inc

3.98B

Cal-Maine Foods Inc

3.79B

Whales Holding HTFL

Summit Partners Public Asset Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Heartflow Inc (HTFL) stock price today?

The current price of HTFL is 30.98 USD — it has decreased -2.36

What is Heartflow Inc (HTFL)'s business?

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

What is the price predicton of HTFL Stock?

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is38.60 USD with a low forecast of 35.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Heartflow Inc (HTFL)'s revenue for the last quarter?

Heartflow Inc revenue for the last quarter amounts to 52.59M USD, increased 41.34

What is Heartflow Inc (HTFL)'s earnings per share (EPS) for the last quarter?

Heartflow Inc. EPS for the last quarter amounts to -0.32 USD, decreased -20.00

How many employees does Heartflow Inc (HTFL). have?

Heartflow Inc (HTFL) has 843 emplpoyees as of May 31 2026.

What is Heartflow Inc (HTFL) market cap?

Today HTFL has the market capitalization of 2.67B USD.